Skip to Content

Genenta to present at the LifeSci Partners Summer Symposium

Jul 30, 2020

MILANO (Italy) / NEW YORK (NY, USA) — Genenta Science, a clinical-stage biotechnology company pioneering the development of a hematopoietic stem cell gene therapy for cancer (Temferon™), today announced that Pierluigi Paracchi, Founder, Chairman and CEO of Genenta, will be presenting a corporate overview at the Private Healthcare Company Virtual Summer Symposium, hosted by LifeSci Partners on August 4 and 5, 2020.